Literature DB >> 12812932

Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease.

David F Moore1, Frank Ye, Raphael Schiffmann, John A Butman.   

Abstract

BACKGROUND AND
PURPOSE: Fabry disease is a multisystem X-linked disorder characterized clinically by angiokeratoma, corneal and lenticular abnormalities, acroparesthesia, and renal and cardiac dysfunction and stroke. We sought to describe novel neuroimaging characteristics of Fabry disease.
METHODS: Neuroradiologic records of 104 hemizygous patients with Fabry disease evaluated between 1994 and 2002 were reviewed. In total, 94 MR studies consisting of T1- and T2-weighted images were examined for the presence of hyperintensity on the T1-weighted images. Additional CT, gradient-echo (T2*-weighted), and fat-suppression MR studies were reviewed to characterize further the T1 abnormality in selected patients. In some patients, cerebral blood flow (CBF) was quantified by using arterial spin tagging (AST).
RESULTS: Overall, 22 patients ( approximately 23%) demonstrated pulvinar hyperintensity on T1-weighted images; the frequency increased with age to over 30% by age 50 years. Susceptibility-weighted T2* studies demonstrated a low-signal-intensity abnormality in the pulvinar in the more severe cases, whereas CT demonstrated the pulvinar to be mineralized. CT attenuation corresponded with an increasing signal intensity on T1-weighted images. Posterior circulation CBF was found to be elevated on individual AST studies, especially in the thalamus.
CONCLUSION: Hyperintensity in the pulvinar on T1-weighted images is a common finding in Fabry disease, likely reflecting the presence of calcification. Although other minreralizing abnormalities may result in calcification of deep gray nuclei, exclusive involvement of the pulvinar may be distinctively characteristic to Fabry disease. Increased CBF in the posterior circulation, particularly the thalamus, suggests that the dystrophic calcification is secondary to cerebral hyperperfusion and selective vulnerability of the pulvinar and adjacent thalamic nuclei. The finding of isolated pulvinar hyperintensity on T1-weighted images should suggest Fabry disease, particularly when seen in conjunction with other nonspecific neuroradiologic manifestations of the disease.

Entities:  

Mesh:

Year:  2003        PMID: 12812932      PMCID: PMC8149001     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  14 in total

1.  Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy.

Authors:  D F Moore; L T Scott; M T Gladwin; G Altarescu; C Kaneski; K Suzuki; M Pease-Fye; R Ferri; R O Brady; P Herscovitch; R Schiffmann
Journal:  Circulation       Date:  2001-09-25       Impact factor: 29.690

2.  Demonstration of scolex in calcified cysticercus lesion using gradient echo with or without corrected phase imaging and its clinical implications.

Authors:  S Chawla; R K Gupta; R Kumar; M Garg; S Pradhan; L Pal; N Husain; A Gupta; R K S Rathore
Journal:  Clin Radiol       Date:  2002-09       Impact factor: 2.350

3.  Enhanced endothelium-dependent vasodilation in Fabry disease.

Authors:  G Altarescu; D F Moore; R Pursley; U Campia; S Goldstein; M Bryant; J A Panza; R Schiffmann
Journal:  Stroke       Date:  2001-07       Impact factor: 7.914

4.  The influence of macromolecular polymerization of spin-lattice relaxation of aqueous solutions.

Authors:  G D Fullerton; M F Finnie; K E Hunter; V A Ord; I L Cameron
Journal:  Magn Reson Imaging       Date:  1987       Impact factor: 2.546

5.  Enzymatic defect in Fabry's disease. Ceramidetrihexosidase deficiency.

Authors:  R O Brady; A E Gal; R M Bradley; E Martensson; A L Warshaw; L Laster
Journal:  N Engl J Med       Date:  1967-05-25       Impact factor: 91.245

6.  Human malignant melanomas with varying degrees of melanin content in nude mice: MR imaging, histopathology, and electron paramagnetic resonance.

Authors:  S W Atlas; B H Braffman; R LoBrutto; D E Elder; D Herlyn
Journal:  J Comput Assist Tomogr       Date:  1990 Jul-Aug       Impact factor: 1.826

7.  Cerebrovascular complications of Fabry's disease.

Authors:  P Mitsias; S R Levine
Journal:  Ann Neurol       Date:  1996-07       Impact factor: 10.422

8.  Quantitative analysis of cerebral vasculopathy in patients with Fabry disease.

Authors:  K E Crutchfield; N J Patronas; J M Dambrosia; K P Frei; T K Banerjee; N W Barton; R Schiffmann
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

9.  Intracranial hematomas: imaging by high-field MR.

Authors:  J M Gomori; R I Grossman; H I Goldberg; R A Zimmerman; L T Bilaniuk
Journal:  Radiology       Date:  1985-10       Impact factor: 11.105

10.  Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease.

Authors:  David F Moore; Gheona Altarescu; Peter Herscovitch; Raphael Schiffmann
Journal:  BMC Neurol       Date:  2002-06-18       Impact factor: 2.474

View more
  39 in total

1.  Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease.

Authors:  Andreas Fellgiebel; Dominik O Wolf; Edwin Kolodny; Matthias J Müller
Journal:  J Inherit Metab Dis       Date:  2011-09-20       Impact factor: 4.982

2.  The pulvinar sign in Fabry patients: the first report in female patients.

Authors:  Alessandro P Burlina; Juan Politei; Sarah Cinque; Andrea Soliani; Robert Y Carlier; Dominique P Germain; Renzo Manara
Journal:  J Neurol       Date:  2011-11-18       Impact factor: 4.849

Review 3.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

4.  Fabry disease with lenticular degeneration without pulvinar sign.

Authors:  Dokyung Lee; Jin Sug Kim; Da Rae Kim; Chun-Gyoo Ihm; Sung Sang Yoon
Journal:  Neurol Sci       Date:  2017-01-19       Impact factor: 3.307

Review 5.  Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.

Authors:  James D Weisfeld-Adams; Ilana B Katz Sand; Justin M Honce; Fred D Lublin
Journal:  Brain       Date:  2015-01-29       Impact factor: 13.501

Review 6.  Single gene disorders causing ischaemic stroke.

Authors:  Saif S M Razvi; Ian Bone
Journal:  J Neurol       Date:  2006-06       Impact factor: 4.849

7.  Invited article: an MRI-based approach to the diagnosis of white matter disorders.

Authors:  Raphael Schiffmann; Marjo S van der Knaap
Journal:  Neurology       Date:  2009-02-24       Impact factor: 9.910

8.  Effects of Age, Gender and Hemispheric Location on T2 Hypointensity in the Pulvinar at 3T.

Authors:  Matthew L White; Yan Zhang; Jason T Helvey; Fang Yu; Matthew F Omojola
Journal:  Neuroradiol J       Date:  2014-12-01

9.  Genomic abnormalities of the murine model of Fabry disease after disease-related perturbation, a systems biology approach.

Authors:  David F Moore; Monique P Gelderman; Paulo A Ferreira; Steven R Fuhrmann; Haiqing Yi; Abdel Elkahloun; Lisa M Lix; Roscoe O Brady; Raphael Schiffmann; Ehud Goldin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

10.  The pulvinar sign: frequency and clinical correlations in Fabry disease.

Authors:  Alessandro P Burlina; Renzo Manara; Catherine Caillaud; Jean-Pierre Laissy; Mariasavina Severino; Isabelle Klein; Alberto Burlina; Olivier Lidove
Journal:  J Neurol       Date:  2008-02-26       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.